Literature DB >> 35487702

Journal Club: Biologics and Potential for Immune Modulation in Chronic Obstructive Lung Disease.

Takudzwa Mkorombindo1, Ron Balkissoon2.   

Abstract

Entities:  

Keywords:  biologics; copd; immune modulation

Year:  2022        PMID： 35487702      PMCID： PMC9166326          DOI： 10.15326/jcopdf.2022.0318

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN： 2372-952X


× No keyword cloud information.
  83 in total

1.  Mepolizumab in corticosteroid-resistant eosinophilic asthma.

Authors:  S Barratt
Journal:  Thorax       Date:  2009-06       Impact factor: 9.139

2.  Obesity causes pulmonary dysbiosis affecting innate immune response in murine asthma model.

Authors:  Marina Caçador Ayupe; Flávia Márcia de Castro E Silva; Erick Esteves de Oliveira; Marcilene Gomes Evangelista Ambrósio; Pollyana Amaral Salvador Freitas; Julliane Dutra Medeiros; Gilson Costa Macedo; Juciane Maria de Castro Andrade; Dionéia Evangelista Cesar; Ana Paula Ferreira
Journal:  Allergy       Date:  2019-07-07       Impact factor: 13.146

3.  Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial.

Authors:  Eugene R Bleecker; J Mark FitzGerald; Pascal Chanez; Alberto Papi; Steven F Weinstein; Peter Barker; Stephanie Sproule; Geoffrey Gilmartin; Magnus Aurivillius; Viktoria Werkström; Mitchell Goldman
Journal:  Lancet       Date:  2016-09-05       Impact factor: 79.321

Review 4.  Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD.

Authors:  Marc Miravitlles; Ariadna Auladell-Rispau; Mònica Monteagudo; Juan Carlos Vázquez-Niebla; Jibril Mohammed; Alexa Nuñez; Gerard Urrútia
Journal:  Eur Respir Rev       Date:  2021-06-23

5.  Epithelial-macrophage-dendritic cell interactions impact alarmins expression in asthma and COPD.

Authors:  Magdalena Paplinska-Goryca; Paulina Misiukiewicz-Stepien; Patrycja Nejman-Gryz; Małgorzata Proboszcz; Michal Mlacki; Katarzyna Gorska; Rafal Krenke
Journal:  Clin Immunol       Date:  2020-04-14       Impact factor: 3.969

Review 6.  The role of genomic profiling in identifying molecular phenotypes in obstructive lung diseases.

Authors:  Stephanie A Christenson
Journal:  Curr Opin Pulm Med       Date:  2020-01       Impact factor: 3.155

7.  Value of metalloproteinases in predicting COPD in heavy urban smokers.

Authors:  Jun-Chieh J Tsay; Yingjie Hu; Judith D Goldberg; Bin Wang; Soumya Vijayalekshmy; Ting-An Yie; Katrina Bantis; Daniel H Sterman; William N Rom
Journal:  Respir Res       Date:  2020-09-02

Review 8.  Role of inflammatory cells in airway remodeling in COPD.

Authors:  Yujie Wang; Jiayan Xu; Yaqi Meng; Ian M Adcock; Xin Yao
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-10-12

Review 9.  Unmet need in severe, uncontrolled asthma: can anti-TSLP therapy with tezepelumab provide a valuable new treatment option?

Authors:  Andrew Menzies-Gow; Michael E Wechsler; Chris E Brightling
Journal:  Respir Res       Date:  2020-10-15

10.  NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma.

Authors:  Andrew Menzies-Gow; Gene Colice; Janet M Griffiths; Gun Almqvist; Sandhia Ponnarambil; Primal Kaur; Gennaro Ruberto; Karin Bowen; Åsa Hellqvist; May Mo; Esther Garcia Gil
Journal:  Respir Res       Date:  2020-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.